Atorvastatin API Market Global Projection, Developments Status, Analysis And Trends

Atorvastatin API Market – Overview

The increasing obesity rates, coupled with an increased incidence of cholesterol problems, is increasing the demand for atorvastatin. Reports that review the healthcare industry have been presented by Market Research Future, which produces reports on industry verticals that appraise the market expansion and prospects. The market is positioned to achieve a CAGR of 3.34% while earning revenues worth USD 4,25,804.16 thousand by 2023.

The need to regulate vital cardiovascular functions is the primary factor fuelling the atorvastatin API market globally. The surging use of atorvastatin to treat cardiovascular diseases is fuelling the development of the market for atorvastatin APIs. The market is expected to be motivated market expansions that are expected to be carried out by industry leaders in the approaching CAGR in the forecast period.

Atorvastatin API Market Segmental Analysis

The segmental study of the atorvastatin API market is carried out on the basis of application and region. The application basis of segmenting the atorvastatin API market is carried out on the basis of hypertriglyceridemia, hypercholesterolemia, dyslipidemia, and others. The hypercholesterolemia segment is anticipated to control the market to touch USD 2,10,753.23 thousand by the end of 2023. The high incidence of hypercholesterolemia is anticipated to initiate positive market growth. Also, the segment is expected to display the uppermost CAGR of 4.09% from 2018 to 2023. The regions counted in the atorvastatin API market are Europe, North America, Asia Pacific, the Middle East, and Africa.

Atorvastatin API Market Regional Analysis   

The regional review of the atorvastatin API market includes region such as Europe, North America, Asia Pacific, the Middle East, and Africa. The North American region was in charge of the largest market portion of 40.64% in 2017, and the regional market is expected to record a CAGR of 3.10 % through the forecast period. Moreover, the Asia Pacific is projected to utilize the fastest CAGR. The Chinese regional market is projected to display the maximum development rate of 5.86 % during the forecast period from 2018 to 2023. The European regional market is appraised to surpass USD 1,31,094.04 thousand by the year 2023. The high prevalence of mixed dyslipidemia and hypercholesterolemia are impelling the growth of the Atorvastatin API market in the region. France is the key supplier to the development of the regional market, followed by the UK.

Atorvastatin API Market Competitive Analysis

The trade-offs between the resources needed to manage the challenges in the market are being carried out increasingly to improve the market’s scope for development. The need to establish cost-benefit analysis is leading to enhanced product development in the market. The state of the assets is also thoroughly examined to determine whether an investment is required to maintain the marketing system in its existing, unimproved state. The market competitors are also carefully scrutinizing whether intervention is required to ensure efficient use of society’s resources. The development of the alternative courses of action in terms of both their expenses and consequences are steering the growth of the market. The market players are concentrating on strategies that lead to the highest degree of development in the market. They are also making the most effective use of resources which is dependent on an effective appraisal and planning process.

The outstanding leaders in the Atorvastatin API Market globally are Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Morepen Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Anuh Pharma Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India).

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

Atorvastatin API Industry Updates:

Nov 2018 Zydus Cadila, a well-known Drug maker, has announced that it has received approval from the US health regulator to promote Atorvastatin Calcium tablets, a cholesterol-lowering drug. The group based out of Ahmedabad has obtained final endorsement from the US Food and Drug Administration (USFDA) to sell the drug in the concentrations of 10 mg, 20 mg, 40 mg, and 80 mg respectively.

Cardiac Imaging Software Market Trends, Industry Forecast, Applications, Growth Drivers, Trends & Demands

Global Cardiac Imaging Software Market: Information by Imaging Modalities (Tomography, Ultrasound Imaging and others), End User (Hospital & Clinics and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023

Cardiac Imaging Software Market Review

Medical imaging devices in conjugation with cardiac imaging software eliminate the need for specialized heart imaging devices like cardiac ultrasound, cardiac MRI, and others, thereby, reducing the medical expenses. cvi42, cmr42 are the popular cardiac imaging soft wares in the market. The data recording and easily accessible features of the cardiac imaging software is not dependent on time. The data can be referred to any time in the present and future to derive required medical history about a patient. 

Increase in cardiovascular disease is rising the demand for cardiac imaging software market . Coronary heart disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism are major problems diagnosed by the software. These are the driving factors anticipated to proliferate the global cardiac imaging market growth. However, slacken medical infrastructure and lack of awareness about the product are expected to hinder the market expansion. 8.17% is the expected compound annual growth rate likely to be attained by the global cardiac imaging market in the forecast period of 2017-2023.

Cardiac Imaging Software Market Segmental Analysis

MRFR made a detailed analysis by studying the market scenario in segments to derive an accurate market overview. The cardiac imaging software market is segmented by imaging modalities and end users.

Based on imaging modalities, the cardiac imaging software market is segmented into tomography, ultrasound imaging, radiographic imaging, and combined modalities. The tomography segment is further narrowed down to computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT). The tomography segment is expected to grow with a 7.67 % CAGR during the forecast period of 2017-2023.

By end users, the cardiac imaging software market is segmented into hospitals and clinics, diagnostic centers, and others. The diagnostic centers segment is expected to exhibit accelerated growth with a CAGR of 8.48 %

By region, the cardiac imaging software market is segmented into North America, Europe, Asia Pacific, and the Middle East and Africa.

Cardiac Imaging Software Market Regional Overview

The large cardiac patient population in North America requiring more effective medical monitoring devices is triggering the increase in adoption of cardiac imaging software. This is anticipated to drive the regional cardiac imaging software market growth. North America boasting of its advanced medical infrastructure is supporting the regional market expansion.

Europe possesses the second largest market share for cardiac imaging software led by Germany, France, and the U.K. The large medical devices industry of Germany coupled with the presence of numerous world-class players are driving the European market. The large cardiac patient's population is reflected by the fact that cardiovascular diseases cause more than 1.8 million deaths, represented 45% of all deaths in the European Union (EU) every year.

Asia Pacific is expected to be the fastest growing cardiac imaging software market owing to the shift of cardiopathies towards the developing regions. However, the rice, cereal and dairy-based diets of most of the Asians have resulted in the lowest rates of cardiac disorders and diseases in the region.

On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited availability of medical facilities, and poor political conditions in Africa. The Middle East & Africa is expected to generate moderate growth skewed in favor of the Gulf economies of Saudi Arabia, UAE and others owing to their large economies and developing healthcare infrastructure.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/cardiac-imaging-software-market-4934

Cardiac Imaging Software Market Companies

Key players in the global cardiac imaging software market outlined by MRFR are Koninklijke Philips N.V. (the Netherlands), Siemens Healthineers (Germany), Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Agfa healthcare (U.S.), TOMTEC Imaging Systems GMBH (Germany), Circle Cardiovascular Imaging Inc. (U.S.), CardioComm Solutions Inc. (Canada), Integer Holdings Corporation (U.S.), Pie Medical Imaging (the Netherland), HeartSciences (U.S.), 3mensio Medical Imaging (U.S.), eMedica, S.L. (U.S.). Heart Imaging Technologies, LLC, McKesson Corporation (U.S.), GE Healthcare (U.S.), Medis medical imaging systems (Netherland), Creavo Medical Technologies (U. K), Pixmeo SARL (Switerzland), Fujifilm Holdings Corporation (Japan), and Positron Corporation (US).

Agricultural Biotechnology Market 2020 Size, Share Leading Growth Drivers, Emerging Audience, Emerging Factors, Leading Growth Drivers

Agricultural Biotechnology Market: Information by Crop Type (Soybean, Maize, Cotton, and others), Application (Herbicide Tolerance, Stacked Traits, Insect Tolerance, and others), Technique (Genetic Engineering, Molecular Breeding, Molecular Diagnostics and Tissue Culture) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Global Forecast till 2022

Agricultural Biotechnology Market Overview: 

The global agricultural biotechnology market is showing positive signs of making progress from a valuation of USD 27778.64 million in 2018 with a CAGR of 10.10% during the forecast period of 2019-2024. Market Research Future (MRFR) declared that the growing demand for better crop yield, increased inclusion of advanced technologies, and a rise in investment in the sector would dominate the global agricultural biotechnology market. 

Global Agricultural Biotechnology Market  would get solid backing from various agrarian countries from the developing parts of the world. However, poor financial states can be a big distraction for such markets.   

Agricultural Biotechnology Market Segmentation: 

The global report on the agricultural biotechnology market has been studied by MRFR analysts to understand how the market is creating a strong base for itself. This study includes segments like crop type, application, and technique.  

By crop type, the report on the agricultural biotechnology market can be segmented into maize, cotton, soybean, and others. The soybean sector is getting strong traction from its inclusion in US-China deals. Its nutritional value is substantially high, which is impacting the global market intake.  

By application, the report on the agricultural biotechnology market includes stacked traits, insect tolerance, herbicide tolerance, and others. The insect tolerance segment is getting traction due to the rise in demand for better crop yields.  

By basis of technique, the report on the agricultural biotechnology market has been segmented into molecular diagnostics, molecular breeding, genetic engineering, and tissue culture. The genetic engineering segment would see a hike in its intake as several market players are increasing their investment to spur growth.  

Agricultural Biotechnology Market Regional Analysis: 

North America is making a strong move forward by creating opportunities for easier inclusion of latest technologies, better investment facilities, and others. The regional demand for top-class production, myriad types of crops, and crops for biofuel is expected to boost the regional market growth rate. The US and Canada are making significant progress in the sector. In Latin America, this growth is getting backed by Brazil and Argentina. But the financial setting is not well-developed like the North American region.  

In Europe, the market would gain from rising investment for technologies and high spending for the research and development sector. In Asia Pacific region, agrarian countries would create a strong scope for the market to expand substantially.  

Agricultural Biotechnology Market Competitive Landscape: 

The global market for agricultural biotechnology is benefiting from the rising demand for a higher level of crop yield and reduction in labor. Various companies are working to establish these factors. These companies are Thermo Fisher Scientific (US), Arcadia Biosciences (US)., Biocentury Transgene Co., Ltd (China), Vilmorin & Cie (France), Dr. Chip Biotech Inc. (Taiwan), Evogene Ltd (Israel), Bayer AG (Germany), LGC Biosearch Technologies (US), Corteva Agriscience (US), Eurofins Scientific (Luxembourg), and Yield10 Bioscience, Inc. (US). MRFR enlisted several strategic tools implemented by these companies to understand the growth trajectory. These factors are mainly mergers, collaborations, better innovations, increased spending for research and development projects, marketing strategies, and other routes. These are expected to ease the process of understanding the market and further development of profit-making policies.  

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/agricultural-biotechnology-market-8724

Agricultural Biotechnology Industry News: 

In March 2020, the US-China trade deal revealed promises made by the Chinese government in terms of agricultural biotechnology. China said that they would streamline their technological side to increase the acceptance process of various technologies provided by their US counterpart. The US govt lauded this move as this can ensure revenues reaching billions of dollars. The faster-streamlining procedure will also boost the Chinese agricultural sector. 

Biological Safety Cabinet Market 2020: Size, Share, Trends, Research, Analysis, Growth Rate, Business Opportunities And Competitive Landscape

Biological safety cabinets (BSC) are majorly utilized by the pharmaceutical and biotechnology sectors for various quality control processes, R&D practices, and others where some hazardous research materials may produce aerosols which can contain, such as infectious agents that laboratory workers could inhale.

Biological safety cabinets facilitate laboratory techniques for safe handling the potentially infectious research materials in order to prevent exposure of laboratory personnel and the contamination of the general environment. Some biological safety cabinets also provide a clean work environment to protect cell cultures or sterile apparatus.

Global biological safety cabinet market is growing rapidly mainly due to the growing biotechnology and pharmaceutical sector. Increasing research activities in the Biotechnology led by the burgeoning pharmaceutical sector provide favorable backgrounds for the market to grow exponentially, increasing the demand for biological safety cabinets. Moreover, the rising investments in the medical sector and life sciences are escalating the market on the global platform.

Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global biological safety cabinet market will reach significant growth heights by 2023 registering 7.4% CAGR during the review period (2018 – 2023). Advances in technology majorly drive the market growth, improving such safety equipments.

The increasing demand for effective and advance technology-based products is anticipated to boost the market size of the global biological safety cabinet market. The global biological safety cabinet market has been evaluated as a swiftly growing market in the coming years, and it is expected that the market will have high demand globally.

The global biological safety cabinet market is undergoing a rapid change. Ongoing discussions and proceedings have brought into examination’s competence of existing regulatory frameworks for medical equipments in well-developed as well as in developing regions guaranteeing the performance, quality, and safety.

Global Biological Safety Cabinet Market   - Segments

MRFR has segmented the analysis into four key dynamics for better understanding:  

By Type: Class I, Class II, and Class III.

By Application  Industrial, R&D, and Academic among others.

By End-users: Pharmaceutical & Biotechnology Companies, Diagnostic & Testing Laboratories, and others.

By Regions:  North America, Europe, APAC and the Rest-of-the-World. 

Global Biological Safety Cabinet Market   - Geographical Analysis

The North American region leads the global biological safety cabinet market.  The US among other North American countries, backed by the expanded healthcare industry in the country accounts for the significant market share in the regional market. Moreover, the presence of a well-developed healthcare sector and major market players positively impacts the market growth in the region.

Factors substantiating the market growth include the growing research activities in the Pharmaceutical and biotechnology companies backed by the well-established healthcare sector. The expanding pharmaceutical sector in the region provides suitable backgrounds for the market to grow by increasing the usages of biosafety cabinets in R&D and quality control processes, besides others.

Europe is the second-largest market for biological safety cabinet, which is led by the presence of promising players mainly the UK, and Germany.  Other factors contributing to the regional market growth include a well-developed healthcare sector, huge demand for drug discoveries, increasing healthcare expenditures, and funding for research activities by public & private sectors. 

Western Europe holds the significant market share owing to the major contributions from the UK, Germany, France, and Italy. Eastern Europe, on the other hand, accounts for the fastest growing region owing to the huge opportunities from the untapped market.

The Asia Pacific region is rapidly emerging as a promising market for biological safety cabinet. Substantial investments by Asian pharma companies are resultantly sufficing the exponential progress. Besides, the governmental support for the research in biotechnology led by the continually improving economic conditions is providing impetus to the market growth.

The biological safety cabinet market in the MEA region is expected to witness impeding growth due to the political conditions and poor economy in the African region.

On the other hand, the market in the Middle Eastern region is poised to witness phenomenal growth due well-developed healthcare sector backed by the government’s initiatives and funding. Countries such as Kuwait, Saudi Arabia, Dubai, and Qatar are majorly contributing to the market growth, which in turn, is transforming the market, facilitating it to reach the global space. Cost competitive product development is undoubtedly the key factor driving the regional market growth. 

Global Biological Safety Cabinet Market   - Competitive Analysis

Characterized by the presence of numerous big and small-scale players, the global of biological safety cabinet market appears fiercely competitive and fragmented. Well-established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain a competitive advantage and to maintain their positions in this market. The Key players operating in the market compete based on pricing, product launch, technology launch, and reputation.

Manufacturers adopt modern manufacturing process to ensure safety and convenience. Marketers employ a continuous improvement strategy to analyze and update products, implementing improvements and launching new solutions to meet the changing needs of end-users. Manufacturers strive to fulfill the most restrictive hygienic and sterility standards while ensuring that ergonomics, simplicity, and reliability define the design of their products.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/biological-safety-cabinet-market-6064

Key Players:

Some of the players leading the market include Labconco (U.S.), Thermo Fisher Scientific (U.S.), Esco Micro (Singapore), Kewaunee Scientific (U.S.), The Baker Company (U.S.), NuAire (U.K), Cruma (Spain), Germfree Laboratories (U.S.), Air Science (U.S.), BIOBASE (China), Berner International (U.S.), and Azbil Telstar (Spain).

Industry/ Innovation/ Related News:

November 27, 2018 – Equashield, LLC (US), a leading global provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced that it will launch a new version of its CSTD-enabled Equashield® Pro Robot at the upcoming ASHP Meeting.

Approximately the size of a standard Biological Safety Cabinet, the Equashield Pro is an Automated Pharmacy Compounding System that is used for the safe and efficient preparation of injectable drugs, including hazardous drugs. Moreover, the Equashield Pro facilitates the simple and cost-effective adoption of robotics in hospital pharmacies without the need for costly renovations and maintenance.

Urinary Tract Infection (UTI) Market 2020: Industry Overview, Driving Factors, Segments, Regional Analysis And Competitive Analysis – Forecast To 2023

Urinary Tract Infection (UTI) Market Overview

Global urinary tract infection market is expected to exhibit a moderate 3.6% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a detailed analysis of the global urinary tract infection market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global urinary tract infection (UTI) market are assessed in detail in the report. 

The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global urinary tract infection market are also studied in the report and projections are made for the growth trajectory of each distinct component. The various segments and sub-segments within the global urinary tract infection market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global urinary tract infection market and provides a detailed look at the various competitive strategies employed by players in the global urinary tract infection market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

Urinary tract infections can be caused by a variety of causes, including unsafe sex, lack of hygiene, and diabetes. Urinary tract infections, or UTIs, are more common in women than men, due to inherent complications in the female reproductive system. According to the World Health Organization, 1 million hospitalizations of women occur each year due to UTIs, which affect almost half the female population around the world. The growing prevalence of urinary tract infections among women is likely to be a major driver for the global UTI market over the forecast period. As countries around the world are gearing up to improve women’s health resources, urinary tract infections are likely to be the target of significant government expenditure in the coming years. This is likely to remain a major driver for the urinary tract infection market over the forecast period.

Urinary Tract Infection (UTI) Market Competitive Analysis:

Leading players in the global urinary tract infection market include Bayer AG, GlaxoSmithKline plc, Novartis AG, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., F. Hoffman-La Roche Ltd., AstraZeneca, Cipla Inc., and Johnson & Johnson. Drug development is likely to be a key agenda for players in the global urinary tract infection market over the forecast period.

In November 2019, the U.S. FDA approved a new drug called cefiderocol (Fetroja) for urinary tract infections that have proven to be drug-resistant.

Urinary Tract Infection (UTI) Market Segmentation:

The global urinary tract infection market is segmented on the basis of drug class, clinical indication, end use, and region.

By drug class, the global urinary tract infection market is segmented into quinolones, aminoglycosides, beta-lactam, azoles, and others.

By clinical indication, the global urinary tract infection market is segmented into urethritis, cystitis, pyelonephritis, and others.

By end use, the global urinary tract infection market is segmented into hospitals, self-administration, and others.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/urinary-tract-infection-market-6138

Urinary Tract Infection (UTI) Market Regional Analysis:

North America accounts for the maximum share in the global urinary tract infections market, followed by Europe. The U.S. is the leading regional market within the North America regional segment, as the U.S. has a strong reimbursement system for urinary tract infections, as well as laws such as Medicare and the Affordable Care Act, enabling widespread administration of urinary tract infection drugs. The growing prevalence of diabetes in the U.S. is also likely to be a major driver for the urinary tract infection market in the region.

Asia Pacific is likely to hold significant promise for the global urinary tract infection market over the forecast period due to the growing awareness about UTIs in the region and the growing healthcare sector in countries such as China and India.

Holographic Imaging Market Overview, Global Size, Business Opportunities, Growth And Segments

Holographic Imaging Market Overview: 

Global report on holographic imaging market size is on a track to achieve 30% CAGR during the forecast period of 2018-2023. Market Research Future (MRFR) has identified technological advancement and better inclusion of fund as major reasons for growth. Also, the influence of the healthcare sector is slated to ensure better growth. Holographic imaging devices are known for their ability to produce 3D images by splitting the beam of the light from the laser. This technology is gaining momentum in various research laboratories where microscope plays a crucial role. It is used for biological samples and assist surgeons and physiciansIn training medical teams, holographic imaging is getting substantial traction. The technology is also providing sufficient diagnostic acknowledgement with a proper safety net that prevents any kind of infection.  

On the other side, factors like its high computational cost of processing, inclusion of sophisticated and complicated recording methods, and adverse impact of sunlight on projection can limit the growth possibilities. 

Holographic Imaging Market Segmentation: 

The global holographic imaging market, as discussed in the MRFR report, has been studied with an eye on segments like application, product type, and end-user. 

By product type, the global report on the holographic imaging market has been segmented into microscopes, software, holographic prints, holographic display, and others. Holographic displays are making a good progress in several sectors. IT has been segmented further into touchable, piston, laser, semi-transparent, and others. The touchable segment includes health patch, skin sensor, and others. 

By application, the global market report on holographic imaging includes medical education, surgery preplanning & assistance, medical imaging, digital intimacy, biomedical research, interventional cardiology, and others. The medical imaging segment encompasses dentistry, urology, ophthalmology, orthopedics, otology, and others. 

By end-user, the global market for holographic imaging has been segmented on the basis of research organizations, pharmaceutical and biotechnology companies, hospitals and clinics, academic medical centers, and others. 

Holographic Imaging Market Regional Analysis: 

North America is expected to lead the market as its infrastructural scope to backup the process is better than many other regions. Countries like the US and Canada are expected to use the process in their research laboratories as they are also enjoying a constant flow of funds. 

In the Asia Pacific region, China and South Korea, along with Japan are expected to drive the market ahead with their sophisticated technologies. The market is getting support from the governments with funds and other backups. In India, the growth opportunities are also quite substantial for the market. 

Holographic Imaging Market Competitive Landscape: 

The global holographic imaging market has a substantial growth opportunity as several of the top players are launching their plans to take the market forward. The primary intent is to boost the foothold. This process relies on merger, collaboration, and other research-related developments among many. These companies are Realview Imaging Ltd. (Israel), EchoPixel, Inc. (US), Mach7 Technologies Ltd. (US), zSpace, Inc. (US), Holoxica Ltd. (UK), Ovizio Imaging systems (Belgium), NanoLive SA (Switzerland), Lyncee Tec. (Switzerland), Phase Holographic Imaging AB (Sweden), Eon Reality (US), Zebra Imaging (US), Leia (US), and others. Innovative marketing strategies are also playing a crucial role in taking the market forward. 

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/holographic-images-market-1083

Holographic Imaging Industry News: 

In China, holographic air cast imaging technology is fast becoming a trend as it provides an opportunity to avoid any contact with the actual surface of any object. Researchers believe that this would reduce the chances of cross-infection. The recent outbreak of COVID 19 Coronavirus has spurred the need and this type of tools are now getting installed in several sectors.

Anesthesia Machine Market Analysis, Size, Share, Overview, Growth Analysis And Emerging Technologies

Anesthesia Machine Market Analysis

Global anesthesia machine market is touted to touch USD 14.75 billion at a favorable 7.8% CAGR over the estimated years (2016-2023). An anesthesia machine simply put, is an apparatus used for delivering patients with general anesthesia during a medical procedure. Through this machine, an anesthetist will administer on the patient mild inhalation sedation having nitrous oxide and oxygen for keeping him/her in the conscious state. The new generation machines provide recording facilities and integrated monitoring with HIS (hospital information system).

There are abundant factors that is propelling the growth of the anesthesia machine market. These factors as per the MRFR (Market Research Future) report include technological advancements in Anesthesia Machine Market Analysis, shift to partial anesthesia from general anesthesia, creation of short-acting anesthetics, increasing use of patient monitoring devices and computer-controlled anesthesia, growing number of minimally invasive surgeries regularly, increasing geriatric population, increasing occurrence of chronic diseases such as cancer, high cholesterol and diabetes, rise in urbanization and industrialization, increase in disposable income, increasing investments made by leading manufacturers, technological developments, constant innovations, growing medical tourism and increasing healthcare sector. Miniaturization and portability have resulted in the increasing use of these machines in point of care surgeries. The present-day anesthesia machines unlike those of the yesteryears consume minimal space. Besides, its growing capabilities such as emergency systems (oxygen flush systems), scavenging systems for capturing waste gases, minimal low flow rate and ability of delivering variable flow are also contributing to the market growth. On the contrary, high installation cost and maintenance, risk of infection, scarcity of anesthesiologists, deaths due to overdose and complications mainly pain are factors that may impede the growth of the anesthesia machine market. 

Anesthesia Machine Market Segmentation

MRFR report offers a broad segmental analysis of the anesthesia machine market on the basis of type, source, clinical indications, end users, form and distribution.

Based on type it is segmented into intermittent anesthesia machines, anesthesia machines and others.

Based on clinical indications, the anesthesia machine market is segmented into skin system surgeries, musculoskeletal system surgeries, urinary system surgeries, digestive system surgeries, cardiovascular system surgeries, respiratory system surgeries, eye, ear and nasal surgeries, nervous system surgeries and others.

Based on components, it is segmented into disposables, monitors, ventilators, machines and others.

Based on subject, it is segmented into veterinary and human.

Based on dimensions, the anesthesia machine market is segmented into stand-alone anesthesia machines and portable anesthesia machines.

Based on end users, it is segmented into point of care, hospitals and others.

Anesthesia Machine Market Regional Analysis

By region, the anesthesia machine market covers growth opportunities and latest trends across North America, Middle East and Africa, Europe, Asia Pacific and Rest of the World. Of these, North America will remain the driving force in the market owing to sizeable public expenses on healthcare coupled with growing number of surgeries. The anesthesia machine market in the European region will have the second major share over the estimated years with the UK, France and Germany being the key contributors here. In the APAC region, the anesthesia machine market is expected to grow at the fastest pace due to developing healthcare infrastructure and economic development. China will fuel the growth of the market followed by India. In the Middle East and Africa, the anesthesia machine market is led by Gulf economies of Qatar, Kuwait, UAE, and Saudi Arabia. The market here is to watch for due to high wealth coupled with development of big hospital complexes.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/upcoming-reports/anesthesia-machine-market-6179

Anesthesia Machine Market Key Players

Leading players profiled in the anesthesia machine market include Teleflex Inc, Smiths Medical, Covidien, Mindray DS USA Inc., Koninklijke Philips N.V, GE Healthcare, Draeger, Heyer Medical AG, Fisher & Paykel Healthcare and others.

April 2019- In Tanzania, more than 200 health facilities have recently been equipped with extremely high-tech anesthesia machines. This was launched on April 7, 2019 on the occasion of World Health Day through a project worth 3 million dollars by the government in association with Gradian Health Systems, leading medical technology company based in the US. Known as UAM (Universal Anesthesia Machine), it can help in generating medical oxygen and the best part, work without power. This equipment can help to save money, lives and valuable time at the time of the surgery.

Healthcare HRM System Market Overview, Size, Share, Global Industry Growth Analysis And Trends By Forecast To 2023

Healthcare HRM System Market Overview

Human resource (HR) software is useful for maintaining the confidential data like financial data and information of employees that includes address & contact number. A new report on the global healthcare human resources (HR) software market, published by Market Research Future (MRFR), anticipates that Healthcare HRM System Market could grow at 2.3% CAGR between 2017 and 2023. In terms of value, the market can be worth USD 1.4 Bn by the end of the forecast period.

The chief market driving factor for the global healthcare human resources (HR) software market growth is the incorporation of HR software for various functions like recruitment, bonus management, salary hikes, training, vacation leaves management, and payment benefits management. Introduction of the new tools in the software can contribute to market growth. Such tools include advertisement management, candidate searching, and link up on social media platforms like Facebook and LinkedIn. Other market driving factors include document control, document security, increasing popularity, awareness about new methods, and increase in automation of healthcare. Automation saves time for many administrative activities. However, some factors that restrain the market growth are the rapid increase in cybercrime, data security concerns, and increasing complexity of software due to increasing organization size.

Healthcare HRM System Market Segmentation

The global healthcare human resources (HR) software market segmentation encompasses administration software, end-user, type of software, and organization type. MRFR’s take on the market explores various facets of the market in-depth.

Regarding administration software, this market has been segmented into benefits management, payroll, time & attendance, and others. Regarding end-users, the market has been segmented into pharmaceuticals, hospital & laboratories, and others. Based on the type of software, the market has been segmented into recruiting software, software-as-a-service (SaaS) software, core HR software, and others. In the context of organization type, the market has been segmented into a small business, medium businesses, and large enterprises.

Healthcare HRM System Market Regional Segmentation

A geographical outlining of the global healthcare human resources (HR) software market covers North America, Asia Pacific, Europe, and the Middle East & Africa (MEA).

North America is the largest market development in the healthcare sector and the subsequent availability of advanced medical facilities. Other reasons for market growth in this region are the presence of key market players in the USA and a strong economy. Canada is another powerful economy in this region that has the potential of becoming a significant market.

During the forecast period, the Asia Pacific region can expect high market growth due to the rapid surge in the development of the industries in this region and an increase in the number of healthcare organizations. In developing countries like China and India, the catalyze industry growth is expected during the forecast period. Japan is another major country-specific market due to technological advancement.

During the forecast period, Europe can expect substantial growth due to the increase in the number of several corporate offices in healthcare sectors. Advanced medical facilities are available in Europe too. The strongest economies that hold the potential of emerging as lucrative markets are France, Germany, and the UK.

In the MEA region, the market is limited due to limited availability of technology, low per capita income, less investment in the healthcare sector, lack of skilled medical professionals, and limited availability of medical facilities.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/healthcare-human-resources-software-market-561

Healthcare HRM System Market Key Players

Prominent players in the global healthcare human resources (HR) software market include Ceridian HCM Inc. (USA), CoreHR (Ireland), EmployWise (India), Halogen Software Inc. (Canada), International Business Machine (IBM) Corporation (USA), Kenexa Corporation(USA), Oracle Corporation (USA), Paychex, Inc. (USA), Paycom Software Inc. (USA), PeopleAdmin(USA), SAP SE (Germany), SuccessFactors (USA), SumTotal Systems Inc. (USA), Taleo Corporation(USA), Ultimate Software (USA), and Workday Inc. (USA).

Healthcare HRM System Industry News

Medical Solutions, one of the largest healthcare staffing companies in the USA, has acquired C&A Industries Inc., renowned family-owned staffing and recruitment firms in the country. C&A Industries is the parent company to a portfolio of various workforce solutions providers that include Aureus Group®, AurStaff®, Aureus Medical Group®, Celebrity Staff™, and FocusOne Solutions®. Its non-staffing affiliates are AurTravel® and AurHomes®. 12 AUG 2019

Bariatric Surgery Market Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Study, Competitive Landscape And Potential Of Industry From 2023

Bariatric Surgery Market Research Report: by device (surgical stapler, gastric bands, gastric balloons, adjustable gastric band, and gastric emptying systems), by type (gastric bypass and sleeve gastrectomy), by the end user - Global forecast till 2023

Bariatric Surgery Market Overview

Global bariatric surgery market is expected to exhibit a robust 6.5% CAGR over the forecast period, according to a new research report from Market Research Future (MRFR). The global bariatric surgery market strategy is driven mainly by the growing demand for bariatric surgeries from the urban population in developed economies. The growing prevalence of obesity in urban centers in the West is likely to drive the global bariatric surgery market over the forecast period.

Bariatric surgery is performed to pinch off the patient’s stomach so that their food intake is reduced without compensating on their hunger. Bariatric surgery is mostly performed in individuals with a body mass index of more than 40. Thus, cases of intense obesity with a chance of turning into morbid obesity are mostly the ideal application for bariatric surgeries.

The growing prevalence of obesity around the world is likely to be the major driver for the global bariatric surgery market over the forecast period. The global prevalence of obesity has been driven in the last few decades by the growing popularity of junk food and the growing prevalence of a sedentary lifestyle that doesn’t provide for exercise and active recreation. Bariatric surgery is one of the most direct ways of combating obesity, as the capacity for food intake is itself reduced, leading to smooth weight loss after the surgery.

Advances in bariatric surgery are also likely to drive the demand for bariatric surgery over the forecast period. The growing demand for minimally invasive surgeries is likely to drive innovation in the bariatric surgery market over the forecast period, as manufacturers rush to fulfill the customer demand in the most efficient way possible. The growing number of patients opting for bariatric surgery is likely to drive the global bariatric surgery market over the forecast period.

Bariatric Surgery Market Competitive Analysis:

Leading players in the global bariatric surgery market include Apollo Endosurgery Inc., Olympus Corporation, TransEnterix Surgical Inc., EndoGastric Solutions Inc., Medtronic, Aspire Bariatrics, Mediflex Surgical Products, Intuitive Surgical, ReShape Lifesciences Inc., Cousin Biotech, Allergan, and Johnson & Johnson Services Inc.

Bariatric Surgery Market Segmentation:

The global bariatric surgery market is segmented on the basis of device, type, and end user.

On the basis of the device, the bariatric surgery market is segmented into surgical stapler gastric bands, gastric balloons, gastric emptying systems, electrical stimulation systems, and others.

On the basis of the type, the market is segmented into gastric bypass, sleeve gastrectomy, adjustable gastric band, biliopancreatic diversion with duodenal switch, and others.

On the basis of the end user, the bariatric surgery market is segmented into hospital & clinics, surgical centers, and others.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/bariatric-surgery-market-5693

Bariatric Surgery Market Regional Analysis:

The Americas hold the major share in the global bariatric surgery market due to the high prevalence of obesity in the region. The global bariatric surgery market is likely to receive strong demand from North America in the coming years due to the growing prevalence of obesity among the urban as well as rural populations in the region. The growing awareness among consumers in the region about maintaining an attractive appearance is also likely to lead to a steady rise in the bariatric surgery market in the region over the forecast period. The high disposable income of consumers in the region is also likely to be a major driver for the global bariatric surgery market over the forecast period. According to the CDC, one third of the U.S. population were obese in 2014, leading to strong prospects for the bariatric surgery market in the region.

Europe is also likely to emerge as a major regional market for bariatric surgery in the coming years due to the growing prevalence of obesity in advanced Western economies and the growing availability of government funding for research.

Asia Pacific holds a relatively small share in the global bariatric surgery market, but is likely to exhibit rapid growth over the forecast period, mainly due to the growing prevalence of diabetes in the region.

Healthcare Fraud Detection Software Market Strategic Assessment, Research, Region, Share And Global Expansion By 2024

Global Healthcare Fraud Detection Market: Information by Type (Descriptive Analytics, Predictive Analytics and Prescriptive Analytics), by Component (Services and Software), by Delivery Model (On-Premise and Cloud-Based), by Application (Insurance Claims Review and Payment Integrity), by End User (Private Insurance Payers, Public/Government Agencies and Third Party Service Providers) and by Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2024

Healthcare Fraud Detection Software Market Overview

The problem of fraudulent claims is intensifying in the healthcare sector and is a burden to society. Healthcare fraud detection generally involves account auditing and detective investigation for fraudulent activities. Some of the common healthcare fraud cases include billing for services that are not provided, separate billing for laboratory tests performed together to claim higher reimbursements, usage of healthcare cards by others, and many more. Such fraudulent activities are detected by using statistical, analytical, deep learning, and predictive modeling methods. The healthcare sector is witnessing more payment breaches than ever before due to which the adoption of healthcare fraud detection solutions has gained enormous importance. Market Research Future (MRFR) has launched a new report on the global Healthcare Fraud Detection Software Market and has indicated that the market is primed to capture a CAGR of 26.7% over the forecast period of 2018-2023. The healthcare fraud detection market was valued at USD 639.07 Mn in 2017.

Misinterpretation, as well as intentional deceit in facts related to payments, have given rise to the need for robust fraud detection systems. Various healthcare organizations across the globe are augmenting their anti-fraud initiatives with proprietary detection technologies. Deployment of such solutions helps to reduce common falsification activities such as multiple claims filed by different providers for same patient, intentional misrepresentation of dates, duration, frequency, or description of services provided. As greater number of patients are seeking healthcare insurance, the chance of healthcare fraudulent activities are also increasing manifold.

On the other hand, despite various benefits aligned with fraud detection solutions, their implementation is restricted by time-consuming deployment process and the need for frequent software upgrades.

Healthcare Fraud Detection Software Market Segmentation

The healthcare fraud detection market has been segmented based on component, delivery model, type, application, end-user.

By component, the healthcare fraud detection market has been segmented into services and software.

By delivery model, the healthcare fraud detection market has been segmented into on-premise delivery models and on-demand delivery models.

By type, the healthcare fraud detection market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Descriptive analytics is the base for effective application of predictive or prescriptive analytics and the descriptive analytics segment is thus anticipated to lead the market.  

By application, the healthcare fraud detection market has been segmented into insurance claims review and payment integrity. The insurance claims review segment has been further segmented into post-payment review and prepayment review.

By end-user, the healthcare fraud detection market has been segmented into private insurance payers, government agencies, employers, and others. 

Healthcare Fraud Detection Software Market Regional Analysis

Region-wise, the healthcare fraud detection market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas is governing the global fraud detection market. The rising number of fraudulent activities in the region, along with government initiatives to curb frauds in the healthcare sector is boosting the growth of the market. Increased spending on healthcare IT, the presence of major players in the region, and technological advancements in the region are other driving factors.

The spiraling rise in the number of healthcare forgery and corruption incidents in Europe has significantly driven the healthcare fraud detection market in the region. The governments in the region are endeavoring to integrate IT into the healthcare infrastructure and are outlaying significant amounts on the same.

APAC healthcare fraud detection market is slated to expand at a torrid pace over the forecast period. Swiftly developing healthcare sector, surging incidence rate of cybercrimes in the region, and increased investment in healthcare IT are propelling the growth of the market in APAC.

The MEA market is likely to capture the least share of the market over the forecast period. The majority of the market growth is anticipated to be cornered towards the Middle East, where investments are being poured in for the development of the healthcare sector due to rising incidences of health insurance frauds.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/healthcare-fraud-detection-market-5670

Healthcare Fraud Detection Market Competitive Landscape

International Business Machines Corporation (IBM), Wipro, HCL Technologies, SAS Institute, Northrop Grumman, McKesson, Fair Isaac, Scio Health Analytics, Pondera Solutions, Conduent, Optum, Verscend Technologies, LexisNexis, DXC Technology, and CGI Group are the eminent players in the healthcare fraud detection market.

Healthcare Fraud Detection Industry Updates

August 2019 - Deep Labs, am AI-driven technology company partnered with Visual Connections, provider of a spectrum of cutting-edge IT services and solutions, to develop AI-driven healthcare fraud detection system.